2026 ICD-10-CM Diagnosis Code E76.29Other mucopolysaccharidoses
ICD-10-CM Codes›E00–E89›E70-E88›E76
- Billable — Valid for Submission
- Chronic Condition
E76.29 is a billable ICD-10-CM diagnosis code for other mucopolysaccharidoses. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026). In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified nutritional and metabolic disorders.
Code Identity
Code Classification
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Deficiency of cerebroside-sulfatase
- Deficiency of N-acetylgalactosamine-4-sulfatase
- Maroteaux-Lamy syndrome
- Maroteaux-Lamy syndrome, intermediate form
- Maroteaux-Lamy syndrome, mild form
- Maroteaux-Lamy syndrome, severe form
- Mucopolysaccharidosis, MPS-VII
Tabular List NotesGuidance
Coding notes and annotation back-references applicable to this code.
Inclusion Terms
- beta-Glucuronidase deficiency
- Maroteaux-Lamy (mild) (severe) syndrome
- Mucopolysaccharidosis, types VI, VII
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Chondro-osteodystrophy - E76.29
- beta-glucuronidase - E76.29
- Eccentro-osteochondrodysplasia - E76.29
- Maroteaux-Lamy syndrome (mild) (severe) - E76.29
- Mucopolysaccharidosis - E76.3
- beta-gluduronidase deficiency - E76.29
- Maroteaux-Lamy syndrome - E76.29
- specified NEC - E76.29
- type
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Chondro-osteodystrophy
- Deficiency, deficient
- beta-glucuronidase
- Eccentro-osteochondrodysplasia
- Maroteaux-Lamy syndrome(mild) (severe)
- Mucopolysaccharidosis
- beta-gluduronidase deficiency
- Mucopolysaccharidosis
- Maroteaux-Lamy syndrome
- Mucopolysaccharidosis
- specified NEC
- Mucopolysaccharidosis
- type
- VI
- Mucopolysaccharidosis
- type
- VII
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Mucopolysaccharidoses
group of lysosomal storage diseases each caused by an inherited deficiency of an enzyme involved in the degradation of glycosaminoglycans (mucopolysaccharides). the diseases are progressive and often display a wide spectrum of clinical severity within one enzyme deficiency.
Patient EducationClinical
Carbohydrate Metabolism Disorders
Metabolism is the process your body uses to make energy from the food you eat. Food is made up of proteins, carbohydrates, and fats. Chemicals in your digestive system (enzymes) break the food parts down into sugars and acids, your body's fuel. Your body can use this fuel right away, or it can store the energy in your body tissues.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert E76.29 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About E76.29Overview
Is E76.29 (Other mucopolysaccharidoses) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report other mucopolysaccharidoses on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What is the ICD-9 equivalent of E76.29?
Under the General Equivalence Mappings, other mucopolysaccharidoses converts to ICD-9-CM 277.5 (mucopolysaccharidosis). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
